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Background: Clinical outcomes after isolated infrapopliteal angioplasty for critical
limb ischemia (CLI) in patients on hemodialysis (HD) are largely unknown.
Methods: This study obtained the data from multi-center retrospective study: Japan
BElow-the-knee Artery Treatment multi-center registry (J-BEAT registry). In 898 serial
patients with 1068 who underwent end vascular therapy for CLI from 2004 to 2010,
Subjects were 406 serial patients with 465 limbs who underwent balloon angioplasty
for primary treatment of isolated infrapopliteal lesions. Subjects were classified into
two groups for comparative study of clinical outcomes: the patients on HD: HD group
(242 patients, 283 limbs) and not on HD: non-HD group (164 patients, 182 limbs).
Results: The HD group had a higher percentage of patients with hypertension (83.1
vs. 68.9% P=0.001), coronary artery disease (60.3 vs. 39.0%, P<0.001), major tissue
loss in treated limb (83.0 vs. 73.6%, P=0.014).But,there was no significant statistically
difference in the ratio of diabetic patients (69.0 vs. 68.9%). In twelve-month clinical
results, there was no statistically difference in the rate of major amputation (19.2 vs.
7.3%) between the two groups. However, the percentage of repeat angioplasty for the
treated limb (32.8 vs. 17.5%, p=0.002) and all-caused death (29.5 vs. 14.6 %, p=0.003)
in the HD group was significantly higher than that in non-HD group. The HD group
had a significantly lower rate of freedom from major amputation or all-caused death
in about 542±434 days follow-up compared to the non-HD group (logrank test
p<0.001). In multivariate analysis of major amputation in patients on HD, C-reactive
protein more than 3.0 IU/L (OR=3.32, 95%CI 1.76-6.71, P<0.001), diabetes mellitus
(OR=2.58, 95%CI 1.12-4.61, P=0.024) or smoking (OR=2.32, 95%CI 1.16-4.59,
P=0.017) were significant predictors .
Conclusion: The limb salvage rate after infrapopliteal angioplasty for CLI in HD
patients was acceptable at 12 month, but the prognosis was poor in long term outcomes.
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Background: CLI patients frequently present with severely calcified tibial stenoses,
resulting in starvation of blood flow to the feet, continuation of limb pain at rest, and
exacerbation of nonhealing wounds. Endovascular treatment with the Diamondback
360° Orbital PAD System (DB360) may have advantages in modifying calcified lesions
to allow lower pressure adjunctive balloon, less need for bailout stenting and improved
patient outcomes. This prospective, multi-center, randomized pilot study compares the
acute, mid- and long-term outcomes of the DB360 versus plain old balloon angioplasty
(POBA) in calcified infrapopliteal arteries.
Methods: Fifty subjects were randomized to DB360 (25) or POBA (25). Primary
endpoint was acute device success of ≤ 30% residual stenosis with no dissection type
C-F. Symptomatic improvements, revascularization rates and economic data were
recorded.
Results: All patients had CLI and calcified infrapopliteal lesions; Rutherford 4 (rest
pain) 50%, Rutherford 5 (minor tissue loss) 42%, and Rutherford 6 (major tissue loss)
8%. DB360 arm: 30 lesions; 88.5 mm average lesion length; 135 seconds average
device run time; 6.18 atms average max balloon inflation. POBA arm: 35 lesions; 68.5
mm average lesion length; 12.8 atms average max balloon inflation for 112 seconds.
Intraprocedural events included 1 (3.3%) dissection for DB360 versus 5 (14.3%)
dissections for POBA, 1 (2.8%) perforation and 1 (2.8%) embolization for POBA.
Bail-out stenting in 2 (6.7%) DB360 versus 4 (11.4%) POBA lesions. The primary
endpoint was met in 93.3% of DB360 versus 76.5% of POBA lesions. Intraprocedural
economic data showed cost equivalence between both arms. At six months, no deaths
occurred in the DB360 arm versus 4 in the POBA arm. Two major amputations
occurred in the DB360 arm versus 3 (1 major, 2 minor) and 1 revascularization in the
POBA arm. In both arms, ABI improved (.75 to 0.98), and 82% were recategorized as
Rutherford 0-3.
Conclusion: CALCIUM 360 showed that DB360 outperforms POBA in calcified
lesions by reducing major dissections and the need for stenting, both major limitations
in treating CLI patients. Six-month results showed that DB360 did not increase
procedural costs while reducing the ischemic burden of the limb.
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Background: In recent years, endovascular treatment (EVT) of chronic total occlusion
(CTO) of lower extremity arteries has made major advances with high success rates.
Although treatments with duplex echo-guided recanalization, retrograde approaches,
and subintimal angioplasty using a re-entry device have advanced, they have some
disadvantages. Because of these limitations, safe and reliable methods are required for
performing EVT of CTO of lower extremity arteries.
Methods: We performed EVT using the transvenous intravascular ultrasound (IVUS)-
guided technique (TIG technique). This technique involves crossing the guidewire
through the CTO lesion using images obtained by the IVUS catheter inserted in the
vein parallel to the target artery (Figure). In this study, we investigated the primary
success rate and complications of EVT using the TIG technique, which was performed
in 19 patients with CTO of a lower extremity artery.
Results: Primary success was achieved in all cases using the TIG technique. There
were no complications such as guidewire perforation, arterial rupture after balloon
dilation or stenting, or venous complications associated with this technique.
Conclusion: The TIG technique resulted in a higher primary success and lesser
complication rates, suggesting that this technique is safe and provides optimal results
in EVT of CTO of lower extremity arteries. The TIG technique may be one of the most
effective methods in EVT of lower extremity artery occlusive diseases.
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Background: A totally percutaneous approach to endovascular abdominal aortic
aneurysm repair (PEVAR) has been shown in multiple single center reports to be
feasible. Nonetheless, questions regarding the broader applicability of the approach
remain due to the lack of a randomized multicenter trial. We report the methods and
outcomes from the roll-in phase of the first prospective, multicenter trial of PEVAR.
Methods: Among 19 institutions participating in the PEVAR Trial (NCT01070069),
38 consecutive patients with abdominal aortic aneurysm were enrolled in a roll-in phase
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